DM
PTCT icon

Deerfield Management’s PTC Therapeutics PTCT Stock Holding History

Deerfield Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-471,000
Closed -$15.9M – 91
2019
Q3 		$15.9M Hold
471,000
– – 0.65% 48
2019
Q2 		$21.2M Buy
471,000
+234,000
+99% +$9.24M 0.76% 46
2019
Q1 		$8.92M Buy
+237,000
New +$7.96M 0.34% 62
2014
Q2 		– Sell
-317,530
Closed -$8.3M – 142
2014
Q1 		$8.3M Sell
317,530
-227,497
-42% -$6.11M 0.34% 71
2013
Q4 		$9.25M Sell
545,027
-300,000
-36% -$5.27M 0.48% 57
2013
Q3 		$18.1M Buy
+845,027
New +$14.7M 0.84% 49

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deerfield Management's PTCT Position: Q4 2019 in Review

Deerfield Management sold out of PTC Therapeutics (PTCT) in Q4 2019, closing a stake of 471,000 shares — an estimated $15.9M sold.

Deerfield Management first reported a position in PTCT in Q3 2013 and held it in 6 quarters. The position peaked at $21.2M in Q2 2019. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • Deerfield Management reported no remaining PTC Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Deerfield Management sold 471,000 PTC Therapeutics shares in Q4 2019, an estimated $15.9M.
  • Deerfield Management first reported a position in PTC Therapeutics in Q3 2013 and held it in 6 quarters.
  • Deerfield Management's PTC Therapeutics position peaked at $21.2M in Q2 2019.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on Deerfield Management's 13F filing for Q4 2019, filed 14 Feb 2020.